Nephrotoxic	nephrotoxic	O	DISEASE	OTHERS	I
effects	effects	O	O	O	O
in	in	O	O	O	O
high-risk	high-risk	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
angiography	angiography	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
iodinated	iodinated	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
can	can	O	O	O	O
result	result	O	O	O	O
in	in	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Whether	whether	O	O	O	O
iso-osmolar	iso-osmolar	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
is	is	O	O	O	O
less	less	O	O	O	O
nephrotoxic	nephrotoxic	O	DISEASE	OTHERS	I
than	than	O	O	O	O
low-osmolar	low-osmolar	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
in	in	O	O	O	O
high-risk	high-risk	O	O	O	O
patients	patients	O	O	O	O
is	is	O	O	O	O
uncertain	uncertain	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
conducted	conducted	O	O	O	O
a	a	O	O	O	O
randomized	randomized	O	O	O	O
,	,	O	O	O	O
double-blind	double-blind	O	O	O	O
,	,	O	O	O	O
prospective	prospective	O	O	O	O
,	,	O	O	O	O
multicenter	multicenter	O	O	O	O
study	study	O	O	O	O
comparing	comparing	O	O	O	O
the	the	O	O	O	O
nephrotoxic	nephrotoxic	O	DISEASE	OTHERS	I
effects	effects	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
iso-osmolar	iso-osmolar	O	O	O	O
,	,	O	O	O	O
dimeric	dimeric	O	O	O	O
,	,	O	O	O	O
nonionic	nonionic	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
,	,	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
low-osmolar	low-osmolar	O	O	O	O
,	,	O	O	O	O
nonionic	nonionic	O	O	O	O
,	,	O	O	O	O
monomeric	monomeric	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
,	,	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
study	study	O	O	O	O
involved	involved	O	O	O	O
129	129	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
diabetes	diabetes	O	DISEASE	OTHERS	I
with	with	O	O	O	O
serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
1.5	1.5	O	O	O	O
to	to	O	O	O	O
3.5	3.5	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
who	who	O	O	O	O
underwent	underwent	O	O	O	O
coronary	coronary	O	O	O	O
or	or	O	O	O	O
aortofemoral	aortofemoral	O	O	O	O
angiography	angiography	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
primary	primary	O	O	O	O
end	end	O	O	O	O
point	point	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
peak	peak	O	O	O	O
increase	increase	O	O	O	O
from	from	O	O	O	O
base	base	O	O	O	O
line	line	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
three	three	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
angiography	angiography	O	O	O	O
.	.	O	O	O	O

Other	other	O	O	O	O
end	end	O	O	O	O
points	points	O	O	O	O
were	were	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
of	of	O	O	O	O
0.5	0.5	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
or	or	O	O	O	O
more	more	O	O	O	O
,	,	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
of	of	O	O	O	O
1.0	1.0	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
or	or	O	O	O	O
more	more	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
from	from	O	O	O	O
day	day	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
day	day	O	O	O	O
7	7	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
increased	increased	O	O	O	O
significantly	significantly	O	O	O	O
less	less	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

From	from	O	O	O	O
day	day	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
day	day	O	O	O	O
3	3	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
mean	mean	O	O	O	O
peak	peak	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
0.13	0.13	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
and	and	O	O	O	O
0.55	0.55	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
P=0.001	p=0.001	O	O	O	O
;	;	O	O	O	O
the	the	O	O	O	O
increase	increase	O	O	O	O
with	with	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
minus	minus	O	O	O	O
the	the	O	O	O	O
increase	increase	O	O	O	O
with	with	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
,	,	O	O	O	O
-0.42	-0.42	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
[	[	O	O	O	O
95	95	O	O	O	O
percent	percent	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
-0.73	-0.73	O	O	O	O
to	to	O	O	O	O
-0.22	-0.22	O	O	O	O
]	]	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
64	64	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
3	3	O	O	O	O
percent	percent	O	O	O	O
)	)	O	O	O	O
had	had	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
of	of	O	O	O	O
0.5	0.5	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
or	or	O	O	O	O
more	more	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
17	17	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
65	65	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
26	26	O	O	O	O
percent	percent	O	O	O	O
)	)	O	O	O	O
(	(	O	O	O	O
P=0.002	p=0.002	O	O	O	O
;	;	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
for	for	O	O	O	O
such	such	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
,	,	O	O	O	O
0.09	0.09	O	O	O	O
[	[	O	O	O	O
95	95	O	O	O	O
percent	percent	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
0.02	0.02	O	O	O	O
to	to	O	O	O	O
0.41	0.41	O	O	O	O
]	]	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
patient	patient	O	O	O	O
receiving	receiving	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
had	had	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
of	of	O	O	O	O
1.0	1.0	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
or	or	O	O	O	O
more	more	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
10	10	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
15	15	O	O	O	O
percent	percent	O	O	O	O
)	)	O	O	O	O
did	did	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
mean	mean	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
from	from	O	O	O	O
day	day	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
day	day	O	O	O	O
7	7	O	O	O	O
was	was	O	O	O	O
0.07	0.07	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
and	and	O	O	O	O
0.24	0.24	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
P=0.003	p=0.003	O	O	O	O
;	;	O	O	O	O
value	value	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
minus	minus	O	O	O	O
the	the	O	O	O	O
value	value	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
group	group	O	O	O	O
,	,	O	O	O	O
-0.17	-0.17	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
deciliter	deciliter	O	O	O	O
[	[	O	O	O	O
95	95	O	O	O	O
percent	percent	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
,	,	O	O	O	O
-0.34	-0.34	O	O	O	O
to	to	O	O	O	O
-0.07	-0.07	O	O	O	O
]	]	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Nephropathy	nephropathy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
less	less	O	O	O	O
likely	likely	O	O	O	O
to	to	O	O	O	O
develop	develop	O	O	O	O
in	in	O	O	O	O
high-risk	high-risk	O	O	O	O
patients	patients	O	O	O	O
when	when	O	O	O	O
iodixanol	iodixanol	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
used	used	O	O	O	O
rather	rather	O	O	O	O
than	than	O	O	O	O
a	a	O	O	O	O
low-osmolar	low-osmolar	O	O	O	O
,	,	O	O	O	O
nonionic	nonionic	O	O	O	O
contrast	contrast	O	O	OTHERS	I
medium	medium	O	O	OTHERS	I
.	.	O	O	O	O

